TS

Todd Schwarzinger

Partner at Cleveland Clinic Ventures

Cleveland, Ohio

Overview 

Todd Schwarzinger is a Partner at Cleveland Clinic Ventures, with a strong background in investment banking and corporate finance. He has made significant investments in various healthcare sectors and holds board positions at multiple companies, including Centerline Biomedical and Method AI. Schwarzinger's career highlights include serving as Managing Director at Silicon Valley Bank and Hercules Capital, Inc., as well as making successful investments in companies like Centerline Biomedical.

Work Experience 

  • Partner, Cleveland Clinic Ventures

    2023 - Current

  • GM, Business Development

    2022 - 2023

Cleveland Clinic is a non-profit medical center that combines clinical and hospital care with research and education.

Raised $362,540,000.00 from National Institutes of Health, National Cancer Institute, National Institutes of Health, Agency for Healthcare Research and Quality, The Clorox Company, Charles L. Shor Foundation, National Institutes of Health, National Institutes of Health, LORD Corporation and Robert J. Fogarty.

  • Board Member

    2025

  • Board Observer

    2024

  • Board Member

    2024

  • Board Observer

    2024

  • Board Member

    2022

Centerline Biomedical, a Cleveland Clinic spin-off, is developing an innovative system

Raised $60,405,496.00 from G2 Venture Partners, RIK Enterprises, JobsOhio, Jumpstart Ventures, Cleveland Clinic, GE Healthcare and Device of Tomorrow Capital.

  • Board Member

    2022

Method AI is developing an AI-backed surgical navigation platform to drive improved outcomes for robotic surgical oncology procedures.

  • Board Member

    2022

  • Board Member

    2023

  • Adjunct Professor, Entrepreneurship and Venture Capital

    2020

  • Chief Commercialization Officer, Veale Institute for Entrepreneurship

    2019 - 2022

Articles About Todd

Relevant Websites